Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Invested Capital (2016 - 2025)

Historic Invested Capital for Apyx Medical (APYX) over the last 16 years, with Q3 2025 value amounting to $43.6 million.

  • Apyx Medical's Invested Capital fell 1050.78% to $43.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.6 million, marking a year-over-year decrease of 1050.78%. This contributed to the annual value of $51.8 million for FY2024, which is 1953.84% down from last year.
  • Latest data reveals that Apyx Medical reported Invested Capital of $43.6 million as of Q3 2025, which was down 1050.78% from $45.0 million recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Invested Capital registered a high of $64.4 million during Q4 2023, and its lowest value of $37.9 million during Q4 2022.
  • In the last 5 years, Apyx Medical's Invested Capital had a median value of $48.6 million in 2024 and averaged $49.5 million.
  • In the last 5 years, Apyx Medical's Invested Capital crashed by 3005.79% in 2022 and then surged by 6996.54% in 2023.
  • Apyx Medical's Invested Capital (Quarter) stood at $54.2 million in 2021, then crashed by 30.06% to $37.9 million in 2022, then soared by 69.97% to $64.4 million in 2023, then dropped by 19.54% to $51.8 million in 2024, then fell by 15.93% to $43.6 million in 2025.
  • Its last three reported values are $43.6 million in Q3 2025, $45.0 million for Q2 2025, and $48.1 million during Q1 2025.